Literature DB >> 30457676

Innate-like B cell subsets during immune responses: Beyond antibody production.

Sandra Romero-Ramírez1,2, Itze C Navarro-Hernandez1,3, Rodrigo Cervantes-Díaz1,2, Víctor A Sosa-Hernández1,4, Ernesto Acevedo-Ochoa1,5, Ari Kleinberg-Bild1, Ricardo Valle-Rios6, David E Meza-Sánchez1, José M Hernández-Hernández3, José L Maravillas-Montero1.   

Abstract

B lymphocytes are recognized for their crucial role in the adaptive immunity since they represent the only leukocyte lineage capable of differentiating into Ab-secreting cells. However, it has been demonstrated that these lymphocytes can exert several Ab-independent functions, including engulfing and processing Ags for presentation to T cells, secreting soluble mediators, providing co-stimulatory signals, and even participating in lymphoid tissues development. Beyond that, several reports claiming the existence of multiple B cell subsets contributing directly to innate immune responses have appeared. These "innate-like" B lymphocytes, whose phenotype, development pathways, tissue distribution, and functions are in most cases notoriously different from those of conventional B cells, are crucial to early protective responses against pathogens by exerting "crossover" defensive strategies that blur the established boundaries of innate and adaptive branches of immunity. Examples of these mechanisms include the rapid secretion of the polyspecific natural Abs, increased susceptibility to innate receptors-mediated activation, cytokine secretion, downstream priming of other innate cells, usage of specific variable immunoglobulin gene-segments, and other features. As these new insights emerge, it is becoming preponderant to redefine the functionality of B cells beyond their classical adaptive-immune tasks. ©2018 Society for Leukocyte Biology.

Keywords:  ABCs; B-1 cells; IRA B cells; MZ B cells; NKBs; VH4-34

Mesh:

Substances:

Year:  2018        PMID: 30457676     DOI: 10.1002/JLB.MR0618-227R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  11 in total

1.  B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients.

Authors:  Víctor A Sosa-Hernández; Jiram Torres-Ruíz; Rodrigo Cervantes-Díaz; Sandra Romero-Ramírez; José C Páez-Franco; David E Meza-Sánchez; Guillermo Juárez-Vega; Alfredo Pérez-Fragoso; Vianney Ortiz-Navarrete; Alfredo Ponce-de-León; Luis Llorente; Laura Berrón-Ruiz; Nancy R Mejía-Domínguez; Diana Gómez-Martín; José L Maravillas-Montero
Journal:  Front Immunol       Date:  2020-12-03       Impact factor: 7.561

2.  Identification of a Sensitive Human Immunological Target of Aryl Hydrocarbon Receptor Activation: CD5+ Innate-Like B Cells.

Authors:  Lance K Blevins; Jiajun Zhou; Robert B Crawford; Norbert E Kaminski
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

3.  Severity of SARS-CoV-2 infection is linked to double-negative (CD27- IgD-) B cell subset numbers.

Authors:  Rodrigo Cervantes-Díaz; Víctor Andrés Sosa-Hernández; Jiram Torres-Ruíz; Sandra Romero-Ramírez; Mariana Cañez-Hernández; Alfredo Pérez-Fragoso; José C Páez-Franco; David E Meza-Sánchez; Miriam Pescador-Rojas; Víctor Adrián Sosa-Hernández; Diana Gómez-Martín; José L Maravillas-Montero
Journal:  Inflamm Res       Date:  2021-11-30       Impact factor: 4.575

Review 4.  The Role of B1 Cells in Systemic Lupus Erythematosus.

Authors:  Zhou She; Cuifang Li; Feifeng Wu; Jueyi Mao; Min Xie; Marady Hun; Amin Sheikh Abdirahman; Senlin Luo; Wuqing Wan; Jidong Tian; Chuan Wen
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

5.  Role of Programmed Cell Death Protein-1 and Lymphocyte Specific Protein Tyrosine Kinase in the Aryl Hydrocarbon Receptor- Mediated Impairment of the IgM Response in Human CD5+ Innate-Like B Cells.

Authors:  Jiajun Zhou; Lance K Blevins; Robert B Crawford; Norbert E Kaminski
Journal:  Front Immunol       Date:  2022-04-26       Impact factor: 8.786

6.  Circulating B10 regulatory cells are decreased in severe and critical COVID-19.

Authors:  Rodrigo Cervantes-Díaz; Víctor A Sosa-Hernández; Sandra Romero-Ramírez; Jiram Torres-Ruiz; Alfredo Pérez-Fragoso; David E Meza-Sánchez; Diana Gómez-Martín; José L Maravillas-Montero
Journal:  J Leukoc Biol       Date:  2022-02-24       Impact factor: 6.011

7.  Immunological features of a lung cancer patient achieving an objective response with anti-programmed death-1 blockade therapy.

Authors:  Toshiko Kamata; Shigetoshi Yoshida; Mariko Takami; Fumie Ihara; Hiroko Yoshizawa; Takahide Toyoda; Yuichiro Takeshita; Seiichi Nobuyama; Yukiko Kanetsuna; Tetsuo Sato; Ichiro Yoshino; Shinichiro Motohashi
Journal:  Cancer Sci       Date:  2019-11-29       Impact factor: 6.716

Review 8.  Multiple Functions of B Cells in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Kongyang Ma; Wenhan Du; Xiaohui Wang; Shiwen Yuan; Xiaoyan Cai; Dongzhou Liu; Jingyi Li; Liwei Lu
Journal:  Int J Mol Sci       Date:  2019-11-29       Impact factor: 5.923

Review 9.  The Forgotten Brother: The Innate-like B1 Cell in Multiple Sclerosis.

Authors:  Saar T Halperin; Bert A 't Hart; Antonio Luchicchi; Geert J Schenk
Journal:  Biomedicines       Date:  2022-03-04

Review 10.  The role of antigen-presenting cells in the pathogenesis of COVID-19.

Authors:  Rana Farzi; Parisa Shiri Aghbash; Narges Eslami; Arezou Azadi; Ali Shamekh; Nima Hemmat; Taher Entezari-Maleki; Hossein Bannazadeh Baghi
Journal:  Pathol Res Pract       Date:  2022-03-23       Impact factor: 3.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.